For the first time in 13 years the U.S. Food and Drug Administration has approved two weight loss drugs. Nearly a year after both prescription drugs were approved, Belviq and Qsymia, are available. Both are designed to help adults with a body mass ...
View Complete StoryNearly 40 percent of adults and approximately 17 percent of children and adolescents aged 2-19 years are obese. To help lower those numbers, the U.S. Food and Drug Administration has approved Qsymia to be taken in addition to a reduced-calorie diet ...
View Complete StoryMOUNTAIN VIEW, Calif., June 17, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that a review article has been published online in Expert Opinion on Drug Safety examining the efficacy and safety of Qsymia® (phentermine and ...
View Complete StoryIn April, the FDA approved an amendment and modification to the Risk Evaluation and Mitigation Strategy (REMS) for Qsymia (phentermine and topiramate extended-release) capsules CIV, manufactured by Vivus. The amendment allows Qsymia to be ...
View Complete Story